These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6362769)

  • 1. Muramyl dipeptide increases tolerance to shock and bacterial challenge in mice.
    Ausobsky JR; Cheadle WG; Brosky BG; Polk HC
    Br J Surg; 1984 Feb; 71(2):151-3. PubMed ID: 6362769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of copovithane as a nonspecific immunomodulator in surgically simulated sepsis.
    Hershman MJ; Trachtenberg LS; Pietsch JD; Mooney TH; DeWeese RC; Cheadle WG
    J Invest Surg; 1989; 2(4):423-9. PubMed ID: 2488006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of muramyl dipeptide in the therapy of established experimental bacterial infection.
    Ausobsky JR; Scuitto M; Trachtenberg LS; Polk HC
    Br J Exp Pathol; 1984 Feb; 65(1):1-9. PubMed ID: 6365142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonspecific enhancement of resistance to local bacterial infection in starved mice.
    Galland RB; Trachtenberg LS; Rynerson N; Polk HC
    Arch Surg; 1982 Feb; 117(2):161-4. PubMed ID: 7034676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulatory effects of muramyl dipeptide upon neutrophils isolated from a local bacterial infection.
    Lamont PM; Maier KG; Melton L; Polk HC
    Br J Exp Pathol; 1987 Oct; 68(5):655-61. PubMed ID: 3318904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of muramyl dipeptide and lead acetate on carbon clearance and endotoxin-induced mortality in mice.
    Cheadle WG; Ausobsky JR; Trachtenberg LS; Lamont P; Polk HC
    Am Surg; 1986 Nov; 52(11):613-7. PubMed ID: 3535600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.
    Tanaka A; Nagao S; Nagao R; Kotani S; Shiba T; Kusumoto S
    Infect Immun; 1979 May; 24(2):302-7. PubMed ID: 457275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Containment as a mechanism of nonspecific enhancement of defenses against bacterial infection.
    Polk HC; Lamont PM; Galland RB
    Infect Immun; 1990 Jun; 58(6):1807-11. PubMed ID: 2187809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of the neonate's nonspecific immunity to Klebsiella infection by muramyl dipeptide, a synthetic immunoadjuvant.
    Parant M; Parant F; Chedid L
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3395-9. PubMed ID: 356054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of L18-MDP(Ala), a synthetic derivative of muramyl dipeptide, on nonspecific resistance of mice to microbial infections.
    Osada Y; Mitsuyama M; Une T; Matsumoto K; Otani T; Satoh M; Ogawa H; Nomoto K
    Infect Immun; 1982 Jul; 37(1):292-300. PubMed ID: 6809630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonspecific stimulation of host defenses against bacterial challenge in immunosuppressed mice.
    Galland RB; Heine KJ; Polk HC
    Arch Surg; 1983 Mar; 118(3):333-7. PubMed ID: 6824433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muramyl dipeptide enhances in vitro peritoneal macrophage phagocytic activity.
    McCoy DM; Brown GL; Ausobsky JR; Polk HC
    Am Surg; 1985 Nov; 51(11):634-6. PubMed ID: 4062058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muramyl dipeptide-induced enhancement of phagocytosis of antibiotic pretreated Escherichia coli by macrophages.
    Friedman H; Warren G
    Proc Soc Exp Biol Med; 1984 Sep; 176(4):366-70. PubMed ID: 6379653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muramyl dipeptide protects decomplemented mice from surgically-induced infection.
    Cobb JP; Brown CM; Brown GL; Polk HC
    Int J Immunopharmacol; 1986; 8(7):799-803. PubMed ID: 3781709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonspecific enhancement of host defenses against infection: experimental evidence of a new order of efficacy and safety.
    Polk HC; Calhoun JH; Lowrey LD; Blanchard SP; Brewer RJ; Adams ST; Chedid L
    Surgery; 1981 Aug; 90(2):376-80. PubMed ID: 7020139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
    Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
    J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-specific stimulation of host defenses against a bacterial challenge in malnourished hosts.
    Galland RB; Polk HC
    Br J Surg; 1982 Nov; 69(11):665-8. PubMed ID: 6751460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of indomethacin on increased resistance to bacterial infection and on febrile responses induced by muramyl dipeptide.
    Parant M; Riveau G; Parant F; Dinarello CA; Wolff SM; Chedid L
    J Infect Dis; 1980 Nov; 142(5):708-15. PubMed ID: 7462686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration by muramyl dipeptide of the effect of induced hyperferremia upon Klebsiella infection in mice.
    Brewer RJ; Galland RB; Polk HC
    Infect Immun; 1982 Oct; 38(1):175-8. PubMed ID: 6754611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.